Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Nature Reviews. Rheumatology|June 6, 2012
The advent of biosimilar therapies in rheumatology--"O brave new world"Morton A Scheinberg, Jonathan KayExpert Opinion on Biological Therapy|April 8, 2016
Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiserMorton A Scheinberg, Colin M Hislop, Renee S MartinRMD Open|October 29, 2015
Biosimilars in rheumatology: what the clinician should knowGilberto Castañeda-Hernández, Rodrigo González-Ramírez, Jonathan Kay, et al.Arthritis and Rheumatism|January 26, 2012
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosusWilliam Stohl, Falk Hiepe, Kevin M Latinis, et al.Revista Brasileira De Reumatologia|May 18, 2011
Brazilian biologic registry: BiobadaBrasil implementation process and preliminary resultsDavid C Titton, Ines Guimarães Silveira, Paulo Louzada-Junior, et al.The Lancet. Rheumatology|January 27, 2024
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trialSaira Z Sheikh, Morton A Scheinberg, James Cheng-Chung Wei, et al.Clinical Rheumatology|April 9, 2015
Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASILBárbara P Fafá, Paulo Louzada-Junior, David C Titton, et al.Revista Brasileira De Reumatologia|July 26, 2017
Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases (Registro Brasileiro de Monitoração de Terapias Biológicas - BiobadaBrasil)Claudia Leiko Yonekura, Rene Donizeti Ribeiro Oliveira, David C Titton, et al.Pageof 1